BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23157232)

  • 21. Have microfluidics delivered for drug discovery?
    Chandrasekaran A; Abduljawad M; Moraes C
    Expert Opin Drug Discov; 2016 Aug; 11(8):745-8. PubMed ID: 27266956
    [No Abstract]   [Full Text] [Related]  

  • 22. The zebrafish: a powerful platform for in vivo, HTS drug discovery.
    Delvecchio C; Tiefenbach J; Krause HM
    Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multiplexed chip-based assay system for investigating the functional development of human skeletal myotubes in vitro.
    Smith AS; Long CJ; Pirozzi K; Najjar S; McAleer C; Vandenburgh HH; Hickman JJ
    J Biotechnol; 2014 Sep; 185():15-8. PubMed ID: 24909944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.
    Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ
    J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of computational methods employed in early-stage drug discovery.
    Skjevik AA; Teigen K; Martinez A
    Future Med Chem; 2009 Apr; 1(1):49-63. PubMed ID: 21426070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High throughput screening for biomaterials discovery.
    Algahtani MS; Scurr DJ; Hook AL; Anderson DG; Langer RS; Burley JC; Alexander MR; Davies MC
    J Control Release; 2014 Sep; 190():115-26. PubMed ID: 24993427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragment screening using X-ray crystallography.
    Davies TG; Tickle IJ
    Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On-chip assay for determining the inhibitory effects and modes of action of drugs against xanthine oxidase.
    Naoghare PK; Kwon HT; Song JM
    J Pharm Biomed Anal; 2010 Jan; 51(1):1-6. PubMed ID: 19679420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrated bioanalytical platform for supporting high-throughput serum protein binding screening.
    Zhang J; Shou WZ; Vath M; Kieltyka K; Maloney J; Elvebak L; Stewart J; Herbst J; Weller HN
    Rapid Commun Mass Spectrom; 2010 Dec; 24(24):3593-601. PubMed ID: 21080511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From low- to high-throughput analysis.
    Lévesque A; Gagnon-Carignan S; Lachance S
    Bioanalysis; 2016; 8(2):135-41. PubMed ID: 26652100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragment screening to predict druggability (ligandability) and lead discovery success.
    Edfeldt FN; Folmer RH; Breeze AL
    Drug Discov Today; 2011 Apr; 16(7-8):284-7. PubMed ID: 21315179
    [No Abstract]   [Full Text] [Related]  

  • 38. New hope in the fight against malaria?
    Rodrigues T; Moreira R; Lopes F
    Future Med Chem; 2011 Jan; 3(1):1-3. PubMed ID: 21428820
    [No Abstract]   [Full Text] [Related]  

  • 39. A challenging drug development process in the era of personalized medicine.
    Jørgensen JT
    Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent advances in structure-based drug discovery].
    Honma T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1582-9. PubMed ID: 21089592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.